| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |